Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers Uncover Secrets of Immune System’s Munitions Factory

26.08.2004


Howard Hughes Medical Institute researchers have discovered a new component of the machinery immune cells use to generate a remarkably diverse array of antibodies from a relatively small number of genes.



The discovery reveals important links in the molecular pathway by which complex genetic alterations arm the immune system to target myriad potential bacterial and viral invaders with swiftness and precision. The discovery may also provide welcome new information about lymphoma, a form of leukemia in which certain cells of the immune system proliferate uncontrollably.

“While this is currently pure speculation, it might be that deregulation of AID activity could lead to mutations that could be involved in the evolution of lymphoma.” Frederick W. Alt


Howard Hughes Medical Institute investigator Frederick W. Alt led the research team that published its findings August 26, 2004, in the journal Nature. Alt and lead author Jayanta Chaudhuri are at Children’s Hospital, Boston, and Harvard Medical School.

The studies focus on B cells, specialized immune cells responsible for producing antibodies, and how an enzyme in those cells known as activation-induced cytidine deaminase (AID) triggers mutations of antibody gene segments to produce an assortment of antibody proteins. This process enables the immune system to produce antibodies that will recognize billions of different antigens - the fragments of foreign invaders that are used to call the immune system to arms.

The presence of an antigen on the surface of a B cell stimulates it to produce antibodies. An important step in this process is the activation of AID, which causes largely random mutations in the genes for the antibody segments that recognize antigens. These mutations occur about a million times more frequently than spontaneous mutations in other genes. In this process, known as somatic hypermutation, AID selectively “damages” the DNA strand, prompting the DNA repair system to create the mutations.

AID also triggers class switch recombination, a highly specific process that involves recombining gene segments that encode the part of the antibody molecule that direct it where to take its antigen cargo and how to dispose of it.

A central mystery in the field of immunology, said Alt, has been how AID acts on antibody genes. In previous studies, Alt and his colleagues showed that the enzyme acts on single-stranded DNA and that, for class switch recombination, such single-stranded DNA can be unraveled from native double-stranded DNA during the process of copying its information to RNA, the cell’s template for production of antibody proteins. However, this mechanism could not explain how AID works during somatic hypermutation.

In the current work, Chaudhuri developed techniques to isolate purified AID from B cells and test its activity on the target for somatic hypermutation. In this way, he found that the enzyme requires an unknown co-factor that was critical for AID function and that this co-factor specifically interacts with AID.

Subsequent analysis revealed that Chaudhuri’s protein was replication protein A (RPA), long known to be part of the DNA replication and repair machinery that attaches to single-stranded DNA.

“RPA was never even suspected to be a candidate for such a role, since it was never suspected that it could get into DNA during RNA transcription,” said Alt. “Until now, it was only known to be involved in certain DNA replication and repair pathways.” Chaudhuri also found that after AID “damages” the DNA, it leaves the complex, but RPA remains. “We believe that RPA is sitting there on the DNA, and it’s recruiting DNA repair factors, which is a great link to the repair machinery needed for the next step in the hypermutation pathway,” said Alt. Thus, in retrospect, RPA’s involvement makes biological sense.

The other major discovery, said Alt, was that for AID to interact with RPA, AID must undergo some modification in B cells - a clue to the nature of the machinery that initiates somatic hypermutation, and a topic for future studies in Alt’s lab.

Identifying RPA’s involvement could have implications for understanding lymphomas. “Lymphomas and some mature B cell tumors are known to show aberrant somatic hypermutation and class switching,” said Alt. “Now that we know more about how the AID-RPA complex works, we can begin to address questions of how the aberrant processes might occur.

“While this is currently pure speculation, it might be that deregulation of AID activity could lead to mutations that could be involved in the evolution of lymphoma,” Alt said. “Also, there might be a mutation in AID or its co-factors that would deregulate it and cause it to target other genes,” he said.

Additional studies will seek to connect the AID-RPA complex with the cell’s repair mechanism to further elucidate the somatic hypermutation and class switch recombination processes, said Alt. “We’d like to figure out how those downstream steps in these two different situations lead in one case to mutation and in the other case to recombination,” he said. “Now that we know more about how AID links to the next steps through RPA, we can begin to address this problem, which is a major question in the field.”

Jim Keeley | EurekAlert!
Further information:
http://www.hhmi.org

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>